Whitehawk Therapeutics, Inc.
WHWK- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001422142
No open-market purchases or sales by Whitehawk Therapeutics, Inc. insiders were filed in the last 90 days; 77 institutions reported holding it in 13F filings for Q2 2026, worth $198.0M in total; no superinvestor holds it.
Holders of 5% or more of WHWK
Holders whose latest Schedule 13D or 13G filing reports 5% or more of Whitehawk Therapeutics, Inc., largest stake first. The change is against the holder's previous filing.
| Holder | Latest form | Stake | Change | First filed | Latest filing | Filing |
|---|---|---|---|---|---|---|
| Avoro Capital Advisors LLC | 13D/A | 19.99%18.3M shares | 0.00 ppfrom 19.99% | Dec 23, 20243 filings | May 14, 2026 | SEC |
| Suvretta Capital Management, LLC | 13G | 9.99%4.73M shares | New | Mar 11, 20251 filing | Mar 11, 2025 | SEC |
| ABG Management Ltd. | 13G/A | 9.40%5.68M shares | +3.10 ppfrom 6.30% | Mar 10, 20252 filings | Aug 14, 2026 | SEC |
| QVT Financial LP | 13G | 9.37%2.31M shares | New | Feb 14, 20251 filing | Feb 14, 2025 | SEC |
| Acuta Capital Partners, LLC | 13D/A | 9.00%4.84M shares | +1.20 ppfrom 7.80% | Jan 24, 20252 filings | May 18, 2026 | SEC |
| OrbiMed Advisors LLC | 13G/A | 7.30%3.93M shares | −1.60 ppfrom 8.90% | May 15, 20252 filings | Aug 14, 2026 | SEC |
| Coastlands Capital LP | 13G | 5.98%2.82M shares | New | Aug 25, 20251 filing | Aug 25, 2025 | SEC |
Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.
13D and 13G filings
23 Schedule 13D and 13G filings on Whitehawk Therapeutics, Inc., newest first, including old-format filings without a stake.
| Filed (ET) | Filer | Form | Stake | Change | Event date | Filing |
|---|---|---|---|---|---|---|
| Aug 14, 20265:57 PM ET | OrbiMed Advisors LLCand 1 other | 13G/A | 7.30%3.93M shares | −1.60 ppfrom 8.90% | Jun 30, 2026 | SEC |
| Aug 14, 20264:30 PM ET | ABG Management Ltd.and 12 others | 13G/A | 9.40%5.68M shares | +3.10 ppfrom 6.30% | Jun 30, 2026 | SEC |
| May 18, 20267:03 PM ET | Acuta Capital Partners, LLCand 2 others | 13D/A | 9.00%4.84M shares | +1.20 ppfrom 7.80% | May 14, 2026 | SEC |
| May 14, 20268:04 PM ET | Avoro Capital Advisors LLCand 2 others | 13D/A | 19.99%18.3M shares | 0.00 ppfrom 19.99% | May 12, 2026 | SEC |
| Aug 25, 20254:29 PM ET | Coastlands Capital LPand 4 others | 13G | 5.98%2.82M shares | New | Aug 19, 2025 | SEC |
| May 15, 20256:46 PM ET | OrbiMed Advisors LLCand 1 other | 13G | 8.90%4.17M shares | New | Mar 31, 2025 | SEC |
| May 15, 20253:53 PM ET | Point72 Asset Management, L.P.and 2 others | 13G/A | 0.00%5.09K shares | −6.00 ppfrom 6.00%Below 5% | Mar 31, 2025 | SEC |
| Mar 11, 20257:22 PM ET | Suvretta Capital Management, LLCand 2 others | 13G | 9.99%4.73M shares | New | Mar 4, 2025 | SEC |
| Mar 10, 20254:30 PM ET | ABG Management Ltd.and 12 others | 13G | 6.30%2.91M shares | New | Mar 4, 2025 | SEC |
| Mar 6, 20255:55 PM ET | Desai Neil | 13D/A | 4.90%2.27M shares | −4.30 ppfrom 9.20%Below 5% | Mar 4, 2025 | SEC |
| Mar 5, 20253:58 PM ET | BML Investment Partners, L.P.and 1 other | 13D/A | 4.98%2.44M shares | −4.92 ppfrom 9.90%Below 5% | Mar 5, 2025 | SEC |
| Mar 4, 20255:58 PM ET | Avoro Capital Advisors LLCand 2 others | 13D/A | 19.99%11.9M shares | +5.49 ppfrom 14.50% | Feb 28, 2025 | SEC |
| Feb 24, 202511:38 AM ET | BML Investment Partners, L.P.and 1 other | 13D/A | 9.90%2.44M shares | 0.00 ppfrom 9.90% | Feb 24, 2025 | SEC |
| Feb 14, 20254:59 PM ET | Satter Muneer A | 13G/A | 0.00%659 shares | –Below 5% | Dec 31, 2024 | SEC |
| Feb 14, 20252:00 PM ET | QVT Financial LP | 13G | 9.37%2.31M shares | New | Dec 31, 2024 | SEC |
| Feb 14, 202512:11 PM ET | EcoR1 Capital, LLCand 2 others | 13G/A | 1.40%345.3K shares | –Below 5% | Dec 31, 2024 | SEC |
| Feb 4, 202511:11 AM ET | BML Investment Partners, L.P.and 1 other | 13D/A | 9.90%2.44M shares | 0.00 ppfrom 9.90% | Feb 3, 2025 | SEC |
| Jan 30, 20253:32 PM ET | BML Investment Partners, L.P.and 1 other | 13D | 9.90%2.44M shares | 0.00 ppfrom 9.90% | Jan 30, 2025 | SEC |
| Jan 29, 20257:01 PM ET | Point72 Asset Management, L.P.and 2 others | 13G | 6.00%1.47M shares | New | Jan 22, 2025 | SEC |
| Jan 24, 20252:34 PM ET | Acuta Capital Partners, LLCand 2 others | 13D/A | 7.80%1.92M shares | – | Dec 19, 2024 | SEC |
| Dec 31, 202411:13 AM ET | BML Investment Partners, L.P.and 1 other | 13D | 9.90%2.44M shares | New | Dec 31, 2024 | SEC |
| Dec 23, 20245:26 PM ET | Desai Neil | 13D/A | 9.20%2.26M shares | – | Dec 19, 2024 | SEC |
| Dec 23, 20243:51 PM ET | Avoro Capital Advisors LLCand 2 others | 13D/A | 14.50%3.58M shares | – | Dec 19, 2024 | SEC |
Form 144: proposed insider sales
Notices from officers, directors and other affiliates planning to sell Whitehawk Therapeutics, Inc. shares.
No Form 144 notices for Whitehawk Therapeutics, Inc. are on file.